Introduction 40
Dystonia is a hyperkinetic movement disorder characterized by involuntary co-contraction of 41 agonist and antagonist muscles resulting in abnormal, repetitive movements and pulled or twisted 42 postures that cause varying degrees of disability and pain (Albanese et al., 2013) . The prevalence of 43 dystonia in the general population has been notoriously difficult to determine precisely, due to different 44 methodologies for case classification, but a recent meta-analysis estimated that primary dystonia occurs 45 at a rate of approximately 16 per 100,000 (Steeves et al., 2012) . This is likely an underestimate, as cases 46 frequently go undiagnosed and dystonia can also be a secondary symptom in other motor disorders. 47
While dystonia most often occurs sporadically, mutations in several genes have been identified and 48 linked with specific forms of dystonia (Charlesworth et al., 2013) . Myoclonus-dystonia (DYT11) is a 49 dominantly inherited form of dystonia caused by loss-of-function mutations in the SGCE gene, which 50 encodes the protein epsilon sarcoglycan (ε-SG) (Zimprich et al., 2001) . The vast majority of DYT11 51 patients with SGCE mutations inherit the disorder from the male parent, with markedly reduced 52 penetrance in the offspring of female patients (Asmus et al., 2002; Zimprich et al., 2001) . The disorder is 53 maternally inherited in only 5-10% of cases. This pattern of dominant, primarily paternal inheritance is 54 consistent with imprinting, or epigenetic silencing, of the maternal allele. Indeed, in DNA and RNA 55 samples from human blood SGCE is maternally imprinted, but the imprinting pattern in the brain is 56 unknown (Grabowski et al., 2003) . 57 DYT11 is characterized primarily by involuntary, tic-like jerking of the arms, neck, and trunk 58 (myoclonus) and oftentimes mild to moderate dystonia that worsens with stress (Kyllerman et al., 1990) . 59
Motor symptoms usually appear in childhood or adolescence (Nardocci et al., 2008; Raymond and 60 Ozelius, 1993; Raymond et al., 2008) and are frequently accompanied by psychiatric symptoms, 61
including anxiety, panic attacks, and obsessive compulsive disorder (Peall et al., 2011; Weissbach et al., 62 2013 ). DYT11 is known as alcohol-responsive dystonia given that approximately half of patients with 63 DYT11 report improvement of motor symptoms after consuming alcohol. Strikingly, for these patients, 64 alcohol tends to provide more therapeutic relief than any available pharmacological interventions, 65 which have frequently been ineffective or poorly-tolerated. Unfortunately, the addictive and 66 neurodegenerative consequences of chronic alcohol use preclude its use as a therapeutic option. 67
Although patients generally live an active life of normal span, the motor and psychiatric symptoms of 68 this disorder can cause a great deal of physical and psychosocial distress, significantly impacting the 69 patients' quality of life. 70 A limiting factor in the development of more effective treatment strategies for patients with 71 DYT11 is the lack of understanding of the neural basis of the disorder. While the genetic cause of DYT11 72 has been known for 10 years, the function of ε-SG protein, particularly in the nervous system, and how 73 loss-of-function of ε-SG leads to motor symptoms remains elusive. This issue is not specific to DYT11, 74 but rather a common problem in understanding genetic dystonias. While mutations in the genes 75 encoding α-, β-, γ-, and δ-sarcoglycans cause different forms of muscular dystrophies, no signs or 76 symptoms of muscle disease have been detected in DYT11 patients with mutations in SGCE (Hjermind et 77 al., 2008) . Moreover, electrophysiological and fMRI studies have cited a subcortical origin of the disorder 78 (Marelli et al., 2008; Nitschke et al., 2006; Roze et al., 2008) . Generally, dystonia has been viewed as a 79 disorder of the basal ganglia. Indeed, in patients with DYT11, changes have been observed in the 80 internal global pallidus (GPi), an output structure of the basal ganglia. In particular, studies have shown 81 that gray matter volume of the GPi (Beukers et al., 2011) and firing patterns of individual neurons in the 82
GPi (Welter et al., 2015) correlates with the severity of motor symptoms in patients. Moreover, deep 83 brain stimulation of the GPi is effective for most DYT11 patients, particularly those with SGCE mutations 84 On the other hand, recent studies have shown that dystonia is associated with changes in the 87 activity, structure, and connections of the cerebellum (Draganski et al., 2003; Dresel et al., 2014; Hendrix 88 and Vitek, 2012; Jinnah and Hess, 2006; LeDoux et al., 1993; LeDoux et al., 1995; Prell et al., 2013; 89 Shakkottai, 2014; Song et al., 2014) . In DYT11 patients, there is evidence from fMRI (Beukers et al., 2010; 90 Nitschke et al., 2006; van der Salm et al., 2013) , and PET (Carbon et al., 2013) for increased cerebellar 91 activity. There are also diffusion tensor imaging data to suggest that changes occur in the white matter 92 tracts that connect the cerebellum to the thalamus and other parts of the brain (van der Meer et al., 93 2012). Furthermore, studies on the expression of SGCE and in the human brain and Sgce, the mouse 94 homolog of SGCE, in the rodent brain have suggested that a brain-specific isoform, which might be 95 responsible for the purely neurophysiological phenotype of DYT11, is highly expressed in the principle 96 computational and output neurons of the cerebellum, the Purkinje cells and deep cerebellar nuclei 97 (DCN) neurons, respectively, while it is expressed at lower levels in the different nuclei of the basal 98 ganglia (Ritz et al., 2011; Xiao et al., 2017; Yokoi et al., 2005) . Lastly, the amelioration of symptoms after 99 ethanol ingestion reported by a number of patients with DYT11 points to a role for the cerebellum in 100 this disorder, as the cerebellum is exquisitely sensitive to alcohol. Several labs have demonstrated that 101 alcohol modulates Purkinje cell spiking activity (Chu, 1983; Rogers et al., 1980; Sinclair et al., 1980) , 102 increases inhibitory synaptic transmission in the cerebellum (Carta et al., 2004) , and alters synaptic 103 plasticity at synapses onto Purkinje cells (Belmeguenai et al., 2008; He et al., 2013) . 104
The goal of this study was to establish a mouse model that would enable the investigation of the 105 neural correlates of motor symptoms in DYT11. Previous genetic knockout models have had subtle 106 effects on motor behavior. Mice with a ubiquitous genetic knockout of Sgce exhibited full body jerks and 107 had difficulty learning in a balance beam task (Yokoi et al., 2006) . Conditional knockout of Sgce in 108
Purkinje cells of the cerebellum (Yokoi et al., 2012a) or specifically in the striatum (Yokoi et al., 2012b) , 109 the input nucleus of the basal ganglia, produced milder effects. Importantly, none of these mice exhibited dystonia or alcohol-responsiveness, both prominent features of DYT11. Unfortunately, genetic 111 models of hereditary dystonia have often failed to recapitulate many of the key motor symptoms of the 112 disorder. One possibility for this phenomenon is compensation for the gene that has been knocked out 113 during brain development in rodents (Fremont and Khodakhah, 2012) . 114
In recent years, our laboratory has successfully generated symptomatic mouse models of 115 dystonia using an acute knockdown approach to overcome potential developmental compensation 116 (Calderon et al., 2011; Fremont et al., 2014; Fremont et al., 2017; Fremont et al., 2015) . Here, we used 117 short hairpin ribonucleic acid (shRNA) to knockdown Scge mRNA selectively in the cerebellum or basal 118 ganglia of adult mice. We found that knockdown of Sgce in the cerebellum, but not the basal ganglia, 119 produced overt motor symptoms, including dystonia. Consistent with what is seen in patients, 120 administration of ethanol improved motor symptoms in Sgce knockdown mice but had no effect on 121 motor symptoms of mice with knockdown of the gene that causes primary torsion dystonia (DYT1). We 122 further found that, compared to mice injected with a control shRNA, both Purkinje cells and DCN 123 neurons of the cerebellum fire aberrantly in Sgce knockdown mice. 124
Results 126
We hypothesized that developmental compensation for genetic knockout of Sgce could account 127 for the mild motor symptoms observed in previous mouse models of DYT11. To address this issue, we 128 employed an acute, shRNA-mediated knockdown strategy to generate a symptomatic mouse model of 129 DYT11. This strategy was successful in two previous studies of rapid onset dystonia-parkinsonism 130 (DYT12) (Fremont et al., 2015) and primary torsion dystonia (DYT1) (Fremont and Khodakhah, 2012; 131 Fremont et al., 2017) . observed in DYT11 patients, we injected AAV9 virus encoding shRNA against Sgce mRNA and a GFP 136 reporter (AAV-SGCEshRNA-GFP) into the cerebellum of adult mice ( Figure 1A ). We found that injection 137 of AAV-SGCEshRNA-GFP resulted in expression of the construct throughout the cerebellum without 138 causing any gross morphological abnormalities ( Figure 1B ), as well as significant knockdown of Sgce 139 mRNA as determined by qRT-PCR ( Figure 1C , Mann-Whitney Test, WT vs. NT CB: p = 0.7922; NT CB vs. 140 sgce KD CB 1: p = 0.0079; NT CB vs. sgce KD CB 2: p = 0.0159; N WT = 6, N NT CB = 5, N sgce KD CB 1 = 5, N sgce KD CB 141 2 = 4). To control for shRNA-specific effects, a group of mice were injected with shRNA that does not 142 target any gene in the genome (AAV-shNT-GFP, NT CB). To control for off-target effects of the shRNA, 143 we used two sequences of shRNA that target separate regions of Sgce (Sgce KD CB 1 and Sgce KD CB 2). 144
Mice were injected with either of two shRNA sequences against Sgce into the cerebellum. Their 145
behavior in the open field was assessed by four scorers blind to the condition of the animal using a 146 previously published dystonia scale, where a score greater than or equal to 2 indicates dystonia 147 (Calderon et al., 2011; Fremont et al., 2014; Fremont et al., 2017; Fremont et al., 2015) . Sgce KD CB mice 148 have a time-dependent induction of dystonia, indicated by a dystonia score of 2 or above (Video 1, control to make sure that the surgery itself did not cause motor symptoms. Accordingly, the dystonia 156 scores for sgce KD CB 1 and sgce KD CB 2 mice for time points of 2 weeks or more after injection were 157 significantly different from the dystonia scores of the same animals at < 1 week ( Figure 1Di , p < 0.01, 158
Wilcoxon matched-pairs signed rank test). Consistent with these data, the dystonia scores of sgce KD CB 159 1 and sgce KD CB 2 mice at < 1 week after injection were not significantly different from NT CB mice at 160 the same time point (Figure 1Di , p = 0.81 and p = 0.97, respectively, t-test, Holm-Sidak method). The 161 dystonia scores of sgce KD CB 1 and sgce KD CB 2 were not significantly different (P> 0.05, t-test, Holm-162
Sidak method). 163
Approximately 75% (29/39) of sgce KD CB 1 mice and 60% (23/40) of and sgce KD CB 2 mice 164 developed dystonia. To explore whether the absence of symptoms is due to inefficient knockdown of 165 Sgce or whether it is due to penetrance of the phenotype, we plotted the extent of Sgce knockdown, 166 determined by qRT-PCR, against the dystonia score recorded in a subset of animals ( Figure 1E ). Based on 167 these data, there appears to be a correlation between the severity of symptoms and knockdown of Sgce 168 RNA, consistent with previous data in an shRNA-mediated mouse model of DYT1 (Fremont et al., 2017) . 169
However, we found that while 5/20 Sgce KD CB animals had more than 50% knockdown of Sgce RNA 170 compared to WT, they had a dystonia score of less than 2. It is thus possible that, while the extent of 171 Sgce knockdown explains some variability observed in the behavioral data, incomplete penetrance of 172 the phenotype may also contribute to the variability of the symptoms observed in Sgce KD CB mice.
Upon closer examination of sgce KD CB mice, we noticed that in addition to dystonia, these 174 mice exhibited a range of motor symptoms that we had not observed in some of the other mouse 175 models of movement disorders previously characterized in our laboratory (Video 2). Sgce KD CB mice 176 had difficulty ambulating normally and showed unsteady or mildly ataxic gate, and myoclonic-like 177 movements in addition to overt dystonia. Furthermore, when suspended by the tail, sgce KD CB mice 178 would spin vigorously and, often, continuously. In order to capture the range of motor symptoms 179 observed in sgce KD CB mice more accurately, we generated two new scales to measure the 180 characteristic symptoms seen in this model. The Disability Scale (Table 1 ) took into consideration the 181 frequency of sustained dystonic-like postures and repetitive movements, as well as the level of motor 182 impairment. The Spinning Scale (Table 2 ) was generated to measure the frequency and duration of 183 spinning during a tail suspension test, a symptom unique to sgce KD CB mice compared to our other 184 models of dystonia. The average Spinning Score for a subset of sgce KD CB 1 and sgce KD CB 2 was 2.22 ± 185 0.77 and 2.00 ± 0.88, respectively (Mean ± S.D., N = 13 and 7). The average Disability Score was 3.02 ± 186 0.76 and 2.89 ± 0.79 (Mean ± S.D., N = 14 and 8), respectively. 187
To examine the contribution of the basal ganglia to symptoms in DYT11, we injected shRNA into 188 the striatum and GPi of wild-type mice (sgce KD BG 1 and 2, Figure 2A ). Mice injected with AAV-189
SGCEshRNA-GFP into the basal ganglia developed mildly abnormal motor symptoms, but they did not 190 develop dystonia ( Figure 2B , Video 3, sgce KD BG 1: N = 4, sgce KD BG 2: N = 14). In 5 out of 47 191 observations, animals scored 2 or above on the Dystonia Scale. Unlike the symptoms observed in sgce 192 KD CB mice, which occurred multiple times in the same recording period and persisted over time, these 193 postures did not occur more than once in the same mouse, suggesting that they might have been false 194 positive identification of dystonic-like postures in those incidences. There were no significant differences 195 in the motor symptoms of sgce KD BG 1 and sgce KD BG 2 mice; consequently, only a small subset of 196 mice was injected with sgce KD BG 1 to confirm the observations made in a larger cohort of sgce KD BG 197 2 mice. Motor abnormalities were not observed in mice injected with AAV-shNT-GFP into the basal 198 ganglia ( Figure 2B , Video 3, NT BG, N = 9). 199
As discussed, although sgce KD BG mice did not develop dystonia, they exhibited abnormal 200 motor activity and these were indicated as scores of 1 and 2 on the Dystonia Scale. These higher scores 201 were statistically significant at the three time points examined. Closer examination of the motor 202 behavior of the mice showed that, in many of them, their activity in the periphery of the open field 203 arena was increased; several Sgce KD BG mice appeared to travel around the periphery and avoid the 204
center of the open field chamber more than either WT or NT BG mice ( Figure 2C ). In addition to 205 ambulating more on the periphery, these sgce KD BG animals also appeared to spend less time in A prominent feature of DYT11 that has not yet been reported in any mouse model is the ability 228 of alcohol to lessen the severity of motor symptoms. To examine whether alcohol could improve the 229 motor symptoms observed in sgce KD CB mice, and further validate this new model, we examined the 230 motor behavior of dystonic (dystonia score ≥ 2) sgce KD CB mice in the open field before and after a 231 subcutaneous injection of ethanol (2 g/kg) or physiological saline. To capture the full range of motor 232 symptoms that ethanol might affect, we scored the motor behavior of these mice on all three scales. the open field after EtOH (p = 0.0148, 1Way ANOVA), this was driven largely by a small number of mice, 251 and the effect was not statistically significant after correcting for multiple comparisons (Dunnett's 252 multiple comparisons test, p> 0.05 at each time point). In contrast to EtOH, saline had no effect on the 253 Dystonia Score or distance traveled in sgce KD CB mice (Figure 3 -Supplement 2, Dystonia Score: p = 254 0.9517, Distance Traveled: p = 0.2851, 1way ANOVA). 255
Since we successfully generated a symptomatic mouse model of DYT11, we further sought to 256 examine the underlying neural correlates of motor symptoms in DYT11 using electrophysiological 257
techniques. We hypothesized that if irregular activity of the cerebellum contributes to the motor 258 symptoms in sgce KD CB mice, then the output of the cerebellum, the DCN neurons, must be affected. 259
To that end, we performed extracellular single unit recordings from DCN neurons in awake, head-260 restrained sgce KD CB or NT CB mice. We found that shRNA knockdown of Sgce mRNA in the cerebellum 261 caused aberrant activity of cerebellar output neurons ( Figure 4 ). Specifically, we found that the firing 262 rate of DCN neurons in sgce KD CB mice was reduced (NT CB = 62.9 ± 24.8 spikes/s, n = 9, N = 4 and sgce 263 KD CB = 32.2 ± 19.5 spikes/s, n = 32, N = 8, Mean ± S.D.; Welch's t-test, p = 0.0057). At the same time, 264 the interspike interval coefficient of variation (ISICV) of DCN neurons was increased in sgce KD CB mice 265 (NT CB = 0.50 ± 0.16 and sgce KD CB = 1.00 ± 0.61, Mean ± S.D.; Welch's t-test, p = 0.0002). The ISICV, a 266 frequently used measure of the regularity of the firing rate of a cell, is the standard deviation of the ISI 267 divided by the mean ISI and thus dependent on the average firing rate of the cell. Sgce KD CB mice had a 268 decreased average firing rate, which would result mathematically in a decreased ISICV if the standard 269 deviation of the ISI was unchanged. The significant increase in the ISI CV in sgce KD CB mice 270 demonstrates that despite the decrease in average firing rate, the cells are firing with much greater 271 variability in their ISIs. There were no significant differences in the mode firing rates of sgce KD CB mice Figure 5G ), suggesting that the neurons are not necessarily burst firing at high 290 frequencies, despite the increase in the predominant firing rate. 291
Discussion 293
The primary goal of this study was to test the hypothesis that acute knockdown of Sgce, the 294 mouse homolog of the gene responsible for DYT11 in humans, in adult mice would more accurately 295 model DYT11 by circumventing compensation that might occur in transgenic mouse models where the 296 protein is absent throughout the development of the brain. We found that acute, shRNA-mediated 297 knockdown of Sgce in the cerebellum, but not the basal ganglia, was sufficient to induce dystonia and 298 other motor symptoms in adult mice. Consistent with what has been observed in patients, the motor 299 symptoms of sgce KD CB mice were sensitive to alcohol, distinguishing this model from previous models 300 of DYT11. 301
Previous genetic mouse models of DYT11 include both ubiquitous and cell-type specific Sgce 302 knockout mice. Because the maternal SGCE allele is epigenetically silenced in humans, DYT11 is 303 paternally inherited in the vast majority of cases. In mice, there is no expression of maternally-inherited 304
Sgce (Yokoi et al., 2005) . To reflect the inheritance pattern observed in humans, mouse models of DYT11 305 were generated by crossing male heterozygous Sgce knockout mice with wild-type females. Ubiquitous 306 genetic knockout of Sgce resulted in subtle motor symptoms, including full body jerks and deficits in 307 motor learning in a balance beam task (Yokoi et al., 2006) . In contrast, sgce KD CB mice, which in most 308 symptomatic cases have less than half of wild-type Sgce levels, exhibit myoclonic-and dystonic-like 309 motor symptoms that are responsive to ethanol. Our success in generating symptomatic mice using an 310 acute knockdown approach points to possible rodent-specific, developmental compensation for loss of 311 These symptoms did not persist into adulthood, however, supporting the hypothesis that 316 developmental compensation may occur in genetic knockout animals. One possible source of 317 compensation is the upregulation of genes with related functions. It has been shown that ε-SG forms 318 complexes with the other members of the sarcoglycan family (α, β, γ,δ, and ζ), and also with members of 319 the dystrophin-associated glycoprotein complex (DGC) in the brain (Waite et al., 2016) . It is possible that 320 upregulation of the other members in this complex during development could compensate for loss of 321
Sgce in mice. The shRNA-mediated knockdown approach circumvents possible developmental 322 compensation by knocking down the protein in the adult mouse and may be more effective than 323 previous models of DYT11 for understanding how loss of Sgce leads to motor symptoms. 324
The model presented here is the first description of a mouse model of DYT11 that recapitulates 325 the salient features of DYT11, namely, myoclonic-like movements and dystonia that were responsive to 326 alcohol. However, in addition to overt dystonia, sgce KD CB mice also had difficulty ambulating normally 327 and showed a mildly ataxic gate. While ataxia is uncommon in DYT11 patients, it has been observed in 328 individuals with SGCE mutations (Drivenes et al., 2015; Sun et al., 2016) . It is also worth noting that the 329 most obvious motor symptoms in sgce KD CB mice were observed in the hind limbs and tails of the 330 animals. While lower limb involvement has been reported in some DYT11 cases (Kobylecki et al., 2014) , 331 involvement of the trunk and upper extremities is far more common (Asmus et al., 2002) . It is possible 332 that our method of evaluating symptom severity based on activity in the open field biased us towards 333 highlighting motor dysfunction in the hind limbs and the tail, and limited our ability to detect more 334 severe motor symptoms in the forelimbs and trunk of sgce KD CB mice that can be more carefully 335 scrutinized in a skilled forelimb reaching task. Lastly, sgce KD CB mice exhibited spinning when 336 While sgce KD CB mice exhibit dystonia, we did not perform EMG recordings in agonist and antagonist 357 muscles at the time of recording. We were thus unable to determine whether highly irregular firing was 358 time-locked to dystonic episodes. The increased ISI CV in sgce KD CB mice thus reflects a combination of 359 acute dystonic, and persistent abnormal motor activity in these animals. 360
Cerebellar contribution to DYT11 was examined previously in a Purkinje cell-specific knockout of 361
Sgce. In contrast to our findings and what was reported in ubiquitous Sgce null mice, the symptoms of 362
Purkinje cell knockout mice were quite mild; they exhibited a small deficit in motor learning but had no 363 robust motor abnormalities or myoclonic-like movements, suggesting brain regions other than the 364 cerebellum might contribute to these motor symptoms (Yokoi et al., 2012a ). However, one major 365 difference between the present work and previous work is that our knockdown is not specific to 366 Purkinje cells. It is possible that Sgce, which is expressed in DCN neurons in addition to Purkinje cells 367 (Ritz et al., 2011) , is important for the function of cerebellar output neurons. This is consistent with our 368 finding that the average firing rate is decreased and the ISICV is increased in DCN neurons in sgce KD CB 369 mice. The effect of Sgce knockdown in DCN neurons may provide an alternative explanation for the 370 more severe motor phenotype of Sgce null mice compared to the Purkinje cell-specific knockout. 371
Further experiments are required to determine whether it is the intrinsic activity of DCN neurons that 372 contributes to motor symptoms, or whether it is their synaptic inputs, including Purkinje cells, which 373
were also affected in our study, that lead to erratic cerebellar output and subsequent motor 374 abnormalities. The symptomatic mouse model produced by acute knockdown of Sgce provides a unique 375 opportunity to address these questions. 376
Because so much is known about the microcircuitry of the cerebellum, as well as the channels 377 that contribute to the intrinsic firing rate of cerebellar neurons, understanding how the electrical 378 properties of cerebellar neurons change in sgce KD CB mice will provide insight into the function of ε-SG 379 under normal conditions. Understanding how alcohol acts to relieve dystonic symptoms would identify 380 therapeutic targets for DYT11 in the cerebellum and help elucidate the mechanisms by which alcohol 381 influences cerebellar output. A number of potential targets of ethanol in the brain have been described 382 which is responsible for maintaining tonic inhibitory current in cerebellar granule cells (Stell et al., 2003) . 385
Modulation of inhibitory currents by ethanol via extrasynaptic GABA A receptors is a potential 386 mechanism for restoring the firing rate and regularity of cerebellar neurons, thereby relieving dystonia. 387 While our findings are consistent with a growing body of evidence in support of a role for the 388 cerebellum in DYT11, our results do not rule out the possibility that other brain regions also contribute 389 to the symptoms observed in these mice. Knockdown of Sgce in the basal ganglia induced subtle motor 390 defects in the mice. Frequently, sgce KD BG mice exhibited increased kinetic behavior specifically in the 391
periphery of the open field chamber. An intriguing possibility is that this behavior is related more to the 392 non-motor symptoms associated with DYT11, including obsessive compulsive disorder and anxiety. 393
It is now well-established that there are a number of direct connections between the 394 cerebellum and the basal ganglia. Given the extensive connections between these brain regions and the 395 contributions of both structures to motor control, it has been suggested that movement disorders 396 should be considered less as disorders of a particular brain region, and more as disorders of the motor 397 circuit. This is because dysfunction in one node, i.e. the cerebellum or basal ganglia, can influence the 398 activity of other nodes (Bostan and Strick, 2018) . With that in mind, two things become very clear. First, 399 it is important from a basic science perspective to understand the site of initial dysfunction in the 400 different dystonias in order to truly understand how abnormal movement results from a genetic 401 mutation. In the case of DYT11, our approach suggests that loss-of-function of Sgce can lead to irregular 402 activity of the cerebellum, resulting in motor symptoms. Understanding this link between genetic 403 mutation and motor symptoms will yield important information about cerebellar function in health and 404 disease. Second, the result of the interconnectivity of different brain structures is that there are 405 multiple sites for therapeutic intervention. It has been shown that deep brain stimulation of the GPi, as Two different shRNAs against unique parts of the sgce sequence generated originally by the RNAi 443 consortium were identified and used in the following experiments (Key Resources Table) . AAV9 444 compatible plasmids and AAV9 virus containing each shRNA were generated commercially (Virovek, 445 Hayward, CA, AAV9-U6-shRNA119308-CMV-GFP (Lot# 12-183); AAV9-U6-shRNA_SGCE-CMV-GFP (Lot# 446 13-009), respectively). Each virus has an average titer of 2 x10 13 vg/ml. A 0.22 µm filter sterilized solution 447 containing the virus in DPBS buffer with 0.001% pluronic F-68 was directly injected into the cerebellum 448 or basal ganglia of adult mice. Control AAV9 containing non-targeted (NT) shRNAs under the same 449 promoter containing the same CMV driven GFP at equivalent titer were also purchased (Key Resources 450 Table) . 451 452
Stereotaxic injection of shRNA 453
Male and female C57/Bl6 mice at least 6 weeks of age were anesthetized with 4% isoflurane and placed 454 on a stereotaxic frame (David Kopf Instruments, Tujunga, CA ). Isoflurane anesthesia was maintained at 455 1.5-2% throughout the course of the surgery, which was sufficient to prevent the animal from 456 responding to a toe or tail pinch. A midline incision was made and the surface of the skull was cleaned of 457 all connective tissue. Craniotomies were made over the cerebellum or basal ganglia, and 2 µl shRNA 458 (AAV-SGCEshRNA-GFP or AAV-shNT-GFP) was injected into each injection site at a rate of 0.15 µl/min. 459
After each injection, the syringe was retracted 50 µm and left for at least 5 minutes. For the cerebellum, 460 the following coordinates were used: -6.00 AP, 0 ML, -1.5 DV and -6.96 AP, 0 ML, and 1.5 DV (cerebellar 461 cortex) and -6.00 AP, ±1.8 ML, -2.3 DV (cerebellar nuclei). For the basal ganglia, the following 462 coordinates were used: +0.5 AP, ±2.0 ML, -2.5 DV (striatum) and -0.5 AP, ±2.5 ML, -3.5 DV (GPi). A total 463 of 8 µl was injected into the brain. In these experiments, every effort was made to include all injected 464 animals. However, on rare occasions, an animal was excluded if post-hoc histology revealed a lack of 465 expression of the virus in the targeted brain area or expression of the virus outside the targeted brain 466 area. 467 468
qRT-PCR 469
Mice were anesthetized with isoflurane until breathing slowed to 1 breath per 3 seconds and the animal 470 was completely unresponsive to tail-or toe pinch. The animal was then quickly decapitated. The 471 cerebellum was rapidly dissected, placed in a 1.5 mL Eppindorf tube, and frozen in liquid nitrogen. Analysis was performed using the 2^(-ΔΔC T ) method (Livak and Schmittgen, 2001) . In order to be used 482 for analysis, the threshold cycle (C T ) of two replicates had to be within 0.4 cycles of each other (standard 483 deviation ≤ 0.283). The median C T for each group of replicates was used. ΔC T was calculated by 484 subtracting the C T for gapdh, a housekeeping gene control, from the C T for sgce for each RNA sample. 485 ΔΔC T was calculated by subtracting the mean C T for all WT samples from the C T for each sample. Relative 486 RNA quantity was then determined by calculating 2^(-ΔΔC T ). 487 488 Immunohistochemistry 489
Immunohistochemistry of GFP was used to confirm expression of the virus, which encodes GFP, in the 490 targeted brain region. On rare occasions, animals were excluded when there was either no clear GFP 491 expression in the target area or when there was GFP expressed in regions outside of the target area. 492
Mice were anesthetized with isoflurane and transcardially perfused with phosphate buffered saline 493 (PBS, Thermo Fisher Scientific, Waltham, MA) followed by 4% paraformaldehyde (PFA, Acros Organics, 494
Thermo Fisher Scientific). The brains were dissected and fixed overnight in 4% PFA at 4°C. They were 495 then rehydrated with 30% sucrose for 24-48 hours, rapidly frozen in Optimal Cutting Temperature Compound (OCT, Tissue-Tek) on dry ice, and stored at -80°C. Brains were cut on a cryostat (Leica 497 CM3050 S) into 30 µm sections. Sections were stained with primary antibody against GFP (rabbit, 1:250, 498
Molecular probes, A11122), followed by secondary antibody Alexa 488 (1:400, goat anti rabbit, 499
Invitrogen Life Technologies A11008). Nuclei were labeled with DAPI (1:2000 In order to more accurately examine the range of motor symptoms observed in SGCE KD CB mice and 514 measure the response of motor symptoms to ethanol, we generated the Disability Scale, which 515 considers the frequency of both sustained dystonic-like postures and repetitive movements, and the 516 extent of motor impairment. Behavior in the open field was scored by 4 colleagues blind to the 517 condition of the animal as follows: 0 = Normal, the animal has no observable motor deficit; 1 = slight 518 motor disability, the animal may exhibit unsteady gait or uncoordinated movement, but does not have 519 any repetitive movements or sustained postures; 2 = Mild motor disability, ambulation is mildly 520 impaired, the animal exhibits wide stance, very unsteady gait, back-walking, and/or occasional 521 repetitive movements or sustained postures; 3 = Moderate motor disability, ambulation is moderately 522 impaired; the animal does not properly ambulate, drags itself on its side, and may exhibit frequent 523 sustained dystonic-like postures or repetitive movements; and 4 = severe motor disability, the animal is 524 unable to properly ambulate for most of the duration of the observation, exhibits frequent repetitive 525 movements, and/or sustained dystonic-like postures 526 527
Spinning Scale 528
Sgce KD CB mice exhibited abnormal spinning when suspended by the tail. To quantify this spinning 529 behavior, short video clips of the animal suspended by the tail were shown to 4 observers blind to the 530 condition of the animal and scored as follows: 0 = Not present, the animal does not spin; 1 = mild, the 531 animal spins but not rapidly and only for parts of the video; 2 = moderate, the animal spins rapidly, but 532 not for the full duration of the video; and 3 = severe, the animal is spinning rapidly for the full duration 533 of the video ( 
Ethanol and saline injections 540
A working solution of 0.2 g/mL ethanol (EtOH) in saline was prepared. After a 5 minute baseline period 541 in the open field, sgce KD CB animals were subcutaneously injected with ethanol at a volume of 200 µl 542 for a 20 g mouse, for a final dose of 2 g/kg EtOH. During control trials, animals were injected with an 543 equal volume of physiological saline. The behavior in the open field was recorded every 15 minutes for 544 90 minutes following EtOH injection. Tor1a KD CB mice were generated exactly as previously described 545 (Fremont et al., 2017) . These animals were given the same ethanol treatment, and their behavior in the 546 open field was recorded every 15 minutes for 60 minutes following EtOH injection. Saline-injected 547 animals were followed up to 60 minutes following the injection. The dystonia scores for sgce KD BG mice for time points of 2 weeks or more after injection were 797 significantly different from the dystonia scores of the same animals at 1 week (Wilcoxon matched-pairs 798 signed rank test, p < 0.001). The dystonia scores of sgce KD BG mice at 1 week after injection were not 799 significantly different from NT BG mice at the same time point (t-test, Holm-Sidak method , p =0.36). 800 (C) sgce KD BG 1 (iii) and sgce KD BG 2 mice (iv) appeared to ambulate more in the periphery of the open 801 field chamber than wild-type (i) and NT BG (ii) mice. The first three columns show example tracks from 802 individual mice. The last column depicts the average, which reflects the number of times the center of 803 mass was detected at a pixel in the arena, and excludes frames where the animal did not move. (WT: N = 804 12, NT BG: N = 12, sgce KD BG 1: N = 4; sgce KD BG 2: N = 13) 805 (D) Dystonia score of tor1a KD mice after ethanol injection. Ethanol had no effect of the dystonia score, 832 which reflects the primary symptoms caused by tor1a knockdown, in mice injected with shRNA against 833 tor1a (p = 0.2391, 1way ANOVA, Mean + S.D., N = 5). 834 Video2. In addition to dystonia, sgce KD CB mice exhibit myoclonic-like movements in the open field and 883 spin when suspended by the tail. 884
Video3. Neither sgce KD BG nor NT BG mice developed dystonia, as measured by a score of greater than 885 or equal to 2 in the open field. 886
Video4. EtOH relieves motor symptoms of sgce KD CB mice, as measured on the Disability Scale (p < 887 0.0001, 1way ANOVA, N = 16), Spinning Scale Scale (, p < 0.0001, 1way ANOVA, N = 19), and Dystonia 888 Scale (p < 0.0001, 1way ANOVA, N = 16), but it does not relieve dystonic symptoms of mice injected with 889
shRNA against tor1a, an acute shRNA knockdown model of DYT1 (p = 0.2391, 1way ANOVA, N = 5). 890
Video5. Saline had no effect on the motor symptoms of sgce KD CB mice (p = 0.9517, 1way ANOVA, N = 891 6). 892 
